REGULATORY ISSUES

AIPM activities contribute to the harmonization and unification of requirements to the regulation of medicines in the Russian Federation and the Eurasian Economic Union at all stages – from R&D to state registration and the subsequent realization – in accordance with the international best practices.

As part of activities within committees and working groups AIPM prepares expert conclusions and considers issues of improving procedures for state registration and expertize of medicines as well as ensuring their quality, efficiency and safety in accordance with good pharmaceutical practices (GxP).